Equine infectious diseases 

Following the declaration in recent weeks of an outbreak of equine viral arteritis (EVA) involving several stallions at a breeding centre in the Calvados department (14), with possible secondary outbreaks, the RESPE crisis team* met on Wednesday, November 19, to assess the situation. The meeting also determined the precautionary measures to be implemented and disseminated in the coming days and weeks. Equine viral arteritis (EVA): A reminder about the disease Equine viral arteritis is a viral di

The Thoroughbred Breeders’ Association have published amendments to the 2026 NFSA Breeding Regulations and EVA health testing, stating the following: The TBA welcomed the resumption in supply of the Equip Artervac vaccine in Britain in June this year, which allowed lapsed vaccinated stallions to recommence courses, and stallions never previously vaccinated to initiate a new course, to provide increased protection from Equine Viral Arteritis (EVA), a notifiable disease. As a consequence of

The equine quarterly disease Surveillance report Q3 2025 produced by Equine Infectious Disease Surveillance, is now available. Some of the key updates included in the report are: News articles: • Significant rise in UK equine strangles diagnoses highlights importance of vigilance and vaccination • A new case reporting, real-time analytics platform and weather risk model for Equine Grass Sickness • EIDS autumn advisory: atypical myopathy seasonal cases Focus article: • Tacklin